Global Market Access & Health Policy Co-op

Johnson & Johnson

Jun 10

Applications are closed

Internship
Full-time
Off-cycle Internship
Science
Toronto

Requirements

Currently pursuing a Graduate degree or PhD in an appropriate field (Science, Pharmacy, Biostatistics, Epidemiology, Health Economics, or Public Health).
Achieved strong academic performances (GPA 2.8 - 3.0)
Legally authorized to work in Canada
You should demonstrate excellent time leadership skills and attention to detail
Must be eligible to work 12 months - beginning in September 2024 (full-time 37.5 hours/week)
Strong familiarity with word, excel, and PowerPoint software
Outstanding communication (written and oral) and strong social skills
Ability to problem solve and analyze situations
You should work independently and demonstrates high motivation to surpass expectations

Responsibilities

As a Global Market Access & Health Policy Co-op Associate, you will:
Conduct literature searches and synthesize clinical / real-world data
Be responsible for supporting global health economics and market access tactical plans for our multiple myeloma portfolio
Develop and maintain tools and resources critical to enable effective execution of Global and regional market access strategies
Define and develop tools to improve efficiencies in processes and communications with internal partners

FAQs

What therapy is this role focused on?

This role is focused on a multiple myeloma therapy in late-stage development.

What opportunities will I have in this role?

You will have the opportunity to support launch and pipeline indications for this therapy.

Johnson & Johnson

Hospitals and Health Care

Science & Healthcare

Industry

10,001+

Employees

Mission & Purpose

Profound Change Requires Boldness. Johnson & Johnson is the largest and most diversified healthcare products company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world.